Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S.
10d
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefitHINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ...
Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Morning Overview on MSN
A tiny robotic surgical system just won approval to begin its first human trials
Microbot Medical has secured FDA authorization to move forward with the first human clinical trial of its LIBERTY ...
Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It ...
Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results